Wikisage, the free encyclopedia of the second generation, is digital heritage

Diacomit

From Wikisage
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Diacomit ®contains 250 mg stiripentol[1][2]

[3]


In December 2001 the European Medicines Agency (EMA) granted stiripentol orphan drug status (designation number EU/3/01/071) for the treatment of severe myoclonic epilepsy of infancy (Dravet's syndrome). On 4 January 2007, the EMA granted the drug a marketing authorisation that is valid throughout the European Union Dravet's syndrome does not exist data for combined therapy both valproic acid or clobazam[4]

ATC

http://www.whocc.no/atc_ddd_index/?code=N03AX17

References

References: